CSIMarket
 


Invo Bioscience Inc   (INVO)
Other Ticker:  
 
 

INVO's Net Income Growth by Quarter and Year

Invo Bioscience Inc 's Net Income results by quarter and year




INVO Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 4.30 0.00 0.00
III Quarter September -2.55 -2.48 0.00 0.00
II Quarter June -2.80 -1.82 0.00 0.00
I Quarter March -2.77 0.00 0.00 0.00
FY   -8.12 0.00 0.00 0.00



INVO Net Income third quarter 2022 Y/Y Growth Comment
Invo Bioscience Inc in the third quarter 2022 recorded net loss of $ -2.55 millions.

According to the results reported in the third quarter 2022, Invo Bioscience Inc achieved the best Net Income growth in Medical Equipment & Supplies industry. While Invo Bioscience Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2022.




INVO Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Invo Bioscience Inc 's third quarter 2022 Net Income $ -2.55 millions INVO's Income Statement
Invo Bioscience Inc 's third quarter 2021 Net Income $ -2.48 millions Quarterly INVO's Income Statement
New: More INVO's historic Net Income Growth >>


INVO Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Invo Bioscience Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INVO's III. Quarter Q/Q Net Income Comment
Although Invo Bioscience Inc in the III. Quarter 2022 revealed net loss of $ -2.55 millions, it should be mentioned, that current results point to slight up side relative to the -2.80 millions in the second quarter.

Within Medical Equipment & Supplies industry Invo Bioscience Inc achieved highest sequential Net Income growth. While Invo Bioscience Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INVO's III. Quarter Q/Q Net Income Comment
Even if Invo Bioscience Inc in the III. Quarter 2022 revealed net loss of $ -2.55 millions, it should be mentioned, that those numbers show improvement in contrast to the -2.80 millions in the second quarter.

Within Medical Equipment & Supplies industry Invo Bioscience Inc achieved highest sequential Net Income growth. While Invo Bioscience Inc 's Net Income growth quarter on quarter, overall rank is .


Invo Bioscience Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Net Income 12 Months Ending $ -3.83 $ -3.76 $ -2.77 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Invo Bioscience Inc ' has realized cumulative trailing twelve months net loss of $ -4 millions in the Sep 30 2022 period.
The situation is detiriorating as the cumulative net loss is becoming larger from $ -3.76 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -2.8 millions for the twelve months ending in the quarter a year ago.

Invo Bioscience Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Invo Bioscience Inc ' has realized cumulative trailing twelve months net loss of $ -4 millions in the Sep 30 2022 period.
The situation is getting worse as the cumulative net loss is getting bigger from $ -3.76 millions in the twelve months ending a quarter before and $ -2.8 millions from the TTM period ending Sep 30 2021 Hanne Jacobs mentioned.

Invo Bioscience Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
INVO's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for INVO's Competitors
Net Income Growth for Invo Bioscience Inc 's Suppliers
Net Income Growth for INVO's Customers

You may also want to know
INVO's Annual Growth Rates INVO's Profitability Ratios INVO's Asset Turnover Ratio INVO's Dividend Growth
INVO's Roe INVO's Valuation Ratios INVO's Financial Strength Ratios INVO's Dividend Payout Ratio
INVO's Roa INVO's Inventory Turnover Ratio INVO's Growth Rates INVO's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Sep 30 2022
Bristol myers Squibb Company3.61%$ 3.608 millions
Synaptogenix Inc 3.40%$ 3.401 millions
Resmed Inc 3.37%$ 3.372 millions
Utah Medical Products Inc1.76%$ 1.759 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PNRG's Profile

Stock Price

PNRG's Financials

Business Description

Fundamentals

Charts & Quotes

PNRG's News

Suppliers

PNRG's Competitors

Customers & Markets

Economic Indicators

PNRG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071